Qualifying Therapeutic Discovery Project Grants for the State of Delaware
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
|Applicant Name||Project Name||Grants Awarded for 2009||Grants Awarded for 2010|
|Incyte Corporation||Development of INCB24360 as a treatment for cancerous solid tumors.||$ 244,479.25|
|Incyte Corporation||Development of INCB7839 as a treatment for metastatic breast cancer.||$ 244,479.25|
|Incyte Corporation||Development of INCB18424 as a treatment for myelofibrosis||$ 244,479.25|
|Lake Biosciences LLC||Nerve Stimulation for the Treatment of Stroke||$ 217,500.00|
|Lake Biosciences LLC||Haptoglobin Type as a Prognostic Test for Vasospasm After Subarachnoid Hemorrhage||$ 102,500.00|
|OrPro Therapeutics, Inc||ORP100 Inhaled Mucolytic||$ 24,000.00|
|QPS Holdings LLC||Octreotide Phytate for Injectable Suspension (OPIS)||$ 129,669.47||$ 104,738.52|
|QPS Holdings, LLC||Leuprolide Mesylate for Injectable Suspension (LMIS)||$ 81,053.15||$ 110,893.23|
|QPS Holdings, LLC||Design, synthesis and development of highly selective matrix metalloprotease inhibitors||$ 96,431.23||$ 62,375.43|
|Respiratory Management Technology, Inc||Aerosol-Dispersion||$ 6,747.22||$ 237,732.03|